Capital Market Live • Jun 12, 2026 01:00 PM • Impact Score: 5.0/10 • Severity: MEDIUM

Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream

Impacted Stocks

APLLTD — Alembic Pharma

▲ Bullish +0.2281%

The USFDA approval for generic Tretinoin Cream unlocks access to a material $94 million market in the US. This regulatory milestone provides clear multi-day visibility for revenue expansion in the generics portfolio, which is expected to support a bullish swing trade over the short-to-medium term.

Price at alert: ₹745.15

Track these stocks in your portfolio

Get instant alerts the next time news breaks on stocks you own — free on Android.

Download Investonks Free →